Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Discussion

15 April 2021 (00:00 - 00:00)

Organised by:

7 More presentations in this session

Presentation thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction

Mr G. Neif Vieira Musse (Sao Paulo, BR)

Presentation thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - Commentary

Professor M. Minicucci (Botucatu, BR)

Presentation thumbnail

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - discussion

Presentation thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

Doctor C. Ballantyne (Houston, US)

Presentation thumbnail

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.

Professor U. Landmesser (Berlin, DE)

Access the full session

Session thumbnail

Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)

The Event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

You may be interested in

Congress Presentation

Making personalised prevention everyone's business

Congress Presentation

Implementing healthy lifestyles: what is different at population level vs individuals?

Congress Presentation

Cardiovascular prevention in older adults

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources